HB 446 (2015): relative to access to investigational drugs, biological products, and devices.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 446 (2015): relative to access to investigational drugs, biological products, and devices.” Granite Record, https://graniterecord.org/bill/2015/hb446. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 446 (2015): relative to access to investigational drugs, biological products, and devices. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2015/hb446
- Chicago
- Granite Record. “HB 446 (2015): relative to access to investigational drugs, biological products, and devices.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2015/hb446.
- BibTeX
@misc{bill-2015-hb446, title = {HB 446 (2015): relative to access to investigational drugs, biological products, and devices.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2015/hb446}, note = {Accessed 24 Oct. 2026} }
HB 446 (2015)
relative to access to investigational drugs, biological products, and devices.
- Status: Died on the table
- Term: 2015-2016
- House committee: Judiciary
- Subject: Public and Mental Health
The Story
It was introduced on January 8, 2015 and referred to the House Judiciary committee. The committee held a public hearing on February 10, 2015. The committee met in executive session on February 17, 2015 and February 19, 2015. The majority recommended that the House kill it, and the minority recommended that the House pass it, by a vote of 10–5. The report was placed on the regular calendar. On March 12, 2015 the House voted to lay it on the table on a voice vote. The bill died on the table when the session ended on November 18, 2015, having been set aside and never taken back up.
Sponsors
- Rep. Ted Wright (R - Carr 8) (prime sponsor)
- Rep. Laura Jones (R - Straf 24)
- Rep. Catherine Cheney (R - Straf 17)
- Rep. Peter Hansen (R - Hills 22)
- Rep. Warren Groen (R - Straf 10)
- Rep. Leon Rideout (R - Coos 7)
- Rep. Steven Beaudoin (R - Straf 9)
- Sen. John Reagan (R - SD17)
Hearings and Sessions
- February 10, 2015, 2:00 PM: public hearing, House Judiciary, LOB 205
- February 17, 2015, 10:00 AM: executive session, House Judiciary, LOB 208
- February 19, 2015: executive session, House Judiciary, LOB 208
Votes
- March 12, 2015, House: Lay on Table (Rep Wright) — voice vote, passed
The Docket
- January 8, 2015: Introduced and Referred to Judiciary
- February 10, 2015: Public Hearing: 2/10/2015 2:00 PM LOB 205
- February 17, 2015: Executive Session: 2/17/2015 10:00 AM LOB 208
- February 19, 2015: Continued Executive Session: 2/19/2015 LOB 208
- February 26, 2015: Majority Committee Report: Inexpedient to Legislate for Mar 11 (Vote 10-5; RC); HC19, PG. 428
- February 26, 2015: Minority Committee Report: Ought to Pass
- March 12, 2015: Lay on Table (Rep Wright): MA VV
- November 18, 2015: Died on the Table
Related Bills
- HB 1138 (2016): relative to access to investigational drugs, biological products, and devices.